共 44 条
- [21] DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation Journal of Experimental & Clinical Cancer Research, 38
- [23] Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation Journal of Experimental & Clinical Cancer Research, 39
- [24] High PPT1 expression predicts poor clinical outcome and PPT1 inhibitor DC661 enhances sorafenib sensitivity in hepatocellular carcinoma Cancer Cell International, 22
- [29] Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in hepatocellular carcinoma European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3107 - 3115